Cited by 627Cardiac Fibrosis and RemodelingHeart Failure Treatment and ManagementInflammation biomarkers and pathways

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Inflammatory mediators in chronic heart failure: an overview

Open access

Anker, Stefan D, von Haehling, Stephan·2004·Heart

DOI 10.1136/hrt.2002.007005PMC PMC1768165

Open this paper in CoChat — free account Open PDF

Abstract

hronic heart failure (CHF) represents a major public health burden, and its prognosis is comparable to that of different malignant diseases.Our understanding of CHF has developed from the rather simplistic model of mere pump failure to that of a multisystem disorder which affects not only the cardiovascular system but also the musculoskeletal, renal, neuroendocrine, and immune systems.Thus, the pathophysiology of CHF is exceedingly complex.Therapies to block excessive neuroendocrine activation have become a cornerstone of treatment.CHF progresses because of activation of neurohormones and pro-inflammatory cytokines following an initial cardiac injury or a mutation of the genetic programme.1 Virtually any heart disease can ultimately lead to heart failure, although the initial event leading to the development of this syndrome is in many cases unknown.However, CHF is always the result of some underlying process and the diagnosis cannot stand alone.The activation of the aforementioned systems maintains and worsens CHF.In particular, the activation of the immune system has received considerable interest in the last decade.There are several different components to this system which interact with each other in a complex manner.It is becoming increasingly apparent that inflammatory mediators play a crucial role in the development of CHF, and several strategies to counterbalance different aspects of the inflammatory response are considered.Possible targets involve pro-and anti-inflammatory cytokines and their receptors, endotoxin, adhesion molecules, nitric oxide and nitric oxide synthase, reactive oxygen species, and different types of leucocytes.The purpose of this review is to give a brief overview of the current understanding of the role of inflammation in CHF.Furthermore, we will discuss recent advances in the development of new therapeutic strategies in this field.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/hrt.2002.007005

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure: Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial
Chung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000077913.60364.d2 · Cited by 1,644
Inflammatory Mediators and the Failing Heart
Mann, D. L. (2002) · Circulation Research · doi:10.1161/01.res.0000043825.01705.1b · Cited by 987
Endotoxin and immune activation in chronic heart failure: a prospective cohort study
Niebauer, J., Volk, H.-D., Kemp, M., Dominguez, M., Schumann, R. R., Rauchhaus, M., Poole-Wilson, P. A., Coats, A. J., & Anker, S. D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09286-1 · Cited by 877
Self-citation
Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure
Rauchhaus, M., Doehner, W., Francis, D. P., Davos, C., Kemp, M., Liebenthal, C., Niebauer, J., Hooper, J., Volk, H.-D., Coats, A. J. S., et al. (2000) · Circulation · doi:10.1161/01.cir.102.25.3060 · Cited by 810
Self-citation
Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure.
Tsutamoto, T., Hisanaga, T., Wada, A., Maeda, K., Ohnishi, M., Fukai, D., Mabuchi, N., Sawaki, M., & Kinoshita, M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00494-4 · Cited by 560
The endotoxin-lipoprotein hypothesis
Rauchhaus, M., Coats, A. J. S., & Anker, S. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02690-8 · Cited by 544
Self-citation
Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure
Ferrari, R., Bachetti, T., Confortini, R., Opasich, C., Febo, O., Corti, A., Cassani, G., & Visioli, O. (1995) · Circulation · doi:10.1161/01.cir.92.6.1479 · Cited by 535
Increased circulating cytokines in patients with myocarditis and cardiomyopathy.
Matsumori, A., Yamada, T., Suzuki, H., Matoba, Y., & Sasayama, S. (1994) · Heart · doi:10.1136/hrt.72.6.561 · Cited by 524
Endothelial Dysfunction in Human Disease
Drexler, H., & Hornig, B. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0843 · Cited by 471

Flagged first, then by citations

Show all 33 references

Research works printed but not linked: 1

10.1016/S0735-1097(98)80048-X · DOI

Sorted by citations

Items 501–600 of 626

Association of Redox State of Human Serum Albumin with Severity in Patients with Heart Failure
Nishikawa, T., Shimizu, S., Kamiya, H., Ueyama, J., & Yamada, S. (2022) · International Heart Journal · doi:10.1536/ihj.22-062 · Cited by 2
Plasma levels of pro-inflammatory molecules and their expressions are associated with severity of heart failure: An investigation in Chinese cohort
Xu, Y., Sun, H., Wang, Z., & Wang, Y. (2019) · European Journal of Inflammation · doi:10.1177/2058739219836577 · Cited by 2
Plasma Nitric Oxide Level in Myocardial Disorders with Left Ventricular Diastolic Dysfunction
Elshamaa, M. F., Ea, S., Ya, F., Ea, E., & ., E. A. (2006) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2
Targeting the Toll-System in Cardiovascular Sciences
Földes, G., von Haehling, S., Jankowska, E. A., & Anker, S. D. (2007) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221307779815084 · Cited by 2
Self-citation
Desnutrição e Caquexia: A Importância da Avaliação na Cardiomiopatia Chagásica
Rassi, S., Rassi, D. D. C., & Freitas, A. F. (2022) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210919 · Cited by 2
Adenine suppresses inflammatory response in vascular smooth muscle cells via modulating AMPK/p53/NF-κB cascade
Lin, C., Peng, Y.-H., Chen, H.-M., Lin, Y., Lin, Y., & Kao, S. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178239 · Cited by 1
A Narrative Review on Photobiomodulation-Guided Immunomodulation: Reprogramming Tumor-Associated Macrophages
Singh, D. (2026) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1177/25785478251406479 · Cited by 1
Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart Failure
Vidula, M. K., Schurgers, L. J., Zhao, L., Dib, M., Zhao, M., Wang, Z., Ebert, C., Salman, O., Azzo, J. D., Zamani, P. L., et al. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.124.012734 · Cited by 1
Inflammatory Biomarkers and Clinical Outcomes in Hospitalized Patients with COVID-19 and Pre-Existing Heart Failure: A Single-Center Cohort Study
Craciun, M.-L., Avram, A. C., Pah, A.-M., Văcărescu, C., Mateescu, D.-M., Ilie, A. C., Cotet, I.-G., Vîrzob, C. R. B., Crișan, S., Avram, C., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062209 · Cited by 1
The Confounder in Plain Sight: A Retrospective Pilot Analysis on the Impact of Comorbidity on C-Reactive Protein Utility for Differentiating Bacterial vs. Viral Infections
Perrella, A., Micco, P. D., Trama, U., Salvatore, P., Spirito, A. D., Tiberio, C., Bernardo, M., Capoluongo, N., Flumeri, G. D., Boenzi, R., et al. (2026) · Antibiotics · doi:10.3390/antibiotics15050510 · Cited by 1
Association Between Neutrophil to High‐Density Lipoprotein Cholesterol Ratio and Heart Failure: A Cross‐Sectional Analysis
Lin, Y., & Li, D. (2026) · Health Science Reports · doi:10.1002/hsr2.72766 · Cited by 1
The Roles of Immunity and Autoimmunity in Chronic Heart Failure
von Haehling, S., Doehner, W., & Anker, S. D. (2006) · Springer eBooks · doi:10.1007/3-540-30822-9_10 · Cited by 1
Self-citation
Randomized, Double Blind, Placebo Controlled Trial of Hydrosoluble Ubiquinol and Carnitine in Patients with Heart Failure: Longterm Follow up Results in the Tishcon Study
Mechírová, V., Kumar, A., Singh, R. B., Sharma, R. K., Chattopadhyay, P., Niaz, M. A., Thakur, A. S., Fedačko, J., Pella, D., & Juneja, L. R. (2008) · The Open Nutraceuticals Journal · doi:10.2174/1876396000801010001 · Cited by 1
Multi-level integrative analysis of Protein Protein Interaction networks: connecting completeness, depth and robustness
Blayney, J. K., Zheng, H., Wang, H., & Azuaje, F. J. (2010) · International Journal of Computational Biology and Drug Design · doi:10.1504/ijcbdd.2010.034465 · Cited by 1
High-sensitivity C-reactive Protein and Other Factors as Outcome Predictors in Acute Decompensated Heart Failure
Chen, C., Lee, Y., Chen, H.-M., & Lin, Y.-L. (2009) · Tzu Chi Medical Journal · doi:10.1016/s1016-3190(09)60059-8 · Cited by 1
The effect of moderate running test on serum TNF-α in obese men
(2013) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/3.10.321-326 · Cited by 1
Cardiorenal Signaling Pathways in Heart Failure: Good and Bad News
Rosas-Peralta, M., Palomo‐Piñón, S., Sánchez, G. B., Rodríguez, G. P., & Paniagua-Sierra, J. R. (2016) · Journal of Hypertension and Cardiology · doi:10.14302/issn.2329-9487.jhc-15-864 · Cited by 1
IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
Геннадьевна, К. И., Novikova, D. S., Попкова, Т. В., Udachkina, E. V., Markelova, E. I., Novikov, A. A., Gorbunova, Y. N., Volkov, A. V., Лучихина, Е. Л., Demidova, N. V., et al. (2018) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2018-328-332 · Cited by 1
End-Organ Physiology Under Continuous-Flow Mechanical Circulatory Support
Tuzun, E. (2020) · Springer eBooks · doi:10.1007/978-3-030-47809-4_19 · Cited by 1
Cost-effective heart failure management: Meta-analysis of IV iron therapy in iron-deficient heart failure patients
Myint, P. T., Nandar, P. P., Thet, A. M., & Orasanu, G. (2022) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2022.100204 · Cited by 1
Heart failure and cancer: From active exposure to passive adaption
Du, Y., & Wu, T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.992011 · Cited by 1
Associations of heart failure to prevalence of haematologic- and solid malignancies in southern Sweden: A cross-sectional study
Scholten, M., & Halling, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292853 · Cited by 1
Homeopathic preparation of Allium sativum abrogates OxLDL mediated atherogenic events in macrophages: An in vitro and in silico approach
Mohan, T., Rajkumar, A., Panchalingam, G., Nayak, D., Raghunathan, M., & Kalaiselvi, P. (2024) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2023.100850 · Cited by 1
Frequency & Predictors of Depression in Patients of Chronic Heart Failure with Reduced Ejection Fraction (HFrEF)
Shafiuzzaman, A. B. M., Chowdhury, A. W., Amin, M. G., Islam, K. N., Hoque, A. M., Ali, I. A., & Kashyapi, B. K. (2024) · Bangladesh Heart Journal · doi:10.3329/bhj.v39i2.75692 · Cited by 1
Targeting MuRF1 to Combat Skeletal Muscle Wasting in Cardiac Cachexia: Mechanisms and Therapeutic Prospects
Liu, X., Wen, Y., & Lu, Y. (2024) · Medical Science Monitor · doi:10.12659/msm.945211 · Cited by 2
Cardiorespiratory Disorders
Udovičić, M., Grizelj, D., & Falak, H. (2024) · Clinical gastroenterology · doi:10.1007/978-3-031-69800-2_20 · Cited by 1
Study of Iron Profile and Vitamin B12 in Patients with Heart Failure with Reduced Ejection Fraction
Lamichhane, B. (2025) · Dinkum Journal of Medical Innovations · doi:10.71017/djmi.4.4.d-0418 · Cited by 1
Cardiac Cachexia in Chronic Heart Failure: The Metabolic Facet of CHF
Doehner, W., & Anker, S. D. (2010) · Springer eBooks · doi:10.1007/978-1-84996-153-0_8 · Cited by 1
Self-citation
Diagnosing Destabilized Heart Failure in the Emergency Setting
Gruson, D., Thys, F., & Verschuren, F. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256468 · Cited by 1
The Cytokines and Heart Failure - A Review
Jahan, A., & Ullah, M. (1970) · Cardiovascular Journal · doi:10.3329/cardio.v3i2.9190 · Cited by 1
Cachexia: Therapeutic Immunomodulation Beyond Cytokine Antagonism
von Haehling, S., & Anker, S. D. (2006) · Springer eBooks · doi:10.1007/978-88-470-0552-5_71 · Cited by 1
Self-citation
[The role of cytokines in the development and clinical course of cardiac insufficiency].
Kravchenko, A. Y., & Cherniaeva, I. M. (2013) · PubMed · Cited by 1
Cardiac Cachexia and Its Impact on Survival in Heart Failure Patients
Saboe, A., Tiksnadi, B. B., Purnomowati, A., & Aprami, T. M. (2016) · Indonesian Journal of Cardiology · doi:10.30701/ijc.v36i2.460 · Cited by 1
Pentraxin 3, a novel inflammatory marker in heart failure patients: its expression in whole blood as a function of clinical severity
Cabiati, M., Salvadori, C., Verde, A., & Ry, S. D. (2019) · Frontiers in Drug Chemistry and Clinical Research · doi:10.15761/fdccr.1000114 · Cited by 1
Characteristic of infectious status in patients with acutely decompencated chronic heart failure and its impact on annual prognosis
Костенко, В. А., Sitnikova, M. Y., Skorodumova, E. A., Геннадьевна, С. Е., Федоров, А. Н., Пивоварова, Л. П., Osipova, I. V., Ariskina, O. B., Rysev, A. V., & Повзун, А. С. (2019) · Kardiologiia · doi:10.18087/cardio.2642 · Cited by 1
Impact of comorbidities on the performance of interferon-gamma release assay in an elderly Greek population without overt immunodeficiency
Τσιλικά, Μ., Antonakos, N., Gkavogianni, T., Karageorgos, A., Kyriazopoulou, E., Netea, M. G., & Giamarellos‐Bourboulis, E. J. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106073 · Cited by 1
Cystatin C, a measure of renal function, as prognostic risk marker in acute heart failure : Studies on the cardiorenal syndrome
Lassus, J. P. E. (2011) · Työväentutkimus Vuosikirja · Cited by 1
Cardiac cachexia remains a clinical challenge
Vincent, R. P. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12547 · Cited by 1
Statins in heart failure – A failure?
Reiner, Ž. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.04.003 · Cited by 1
Cardiac cachexia and gastrointestinal system
Ege, M. R., Yılmaz, M. B., & Guray, Y. A. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.02.016 · Cited by 1
Neural Inflammation in Thoracic Dorsal Root Ganglia Mediates Cardiopulmonary Spinal Afferent Sensitization in Chronic Heart FailurePreprint
Hong, J., Gillman, S., Pellegrino, P. R., Zhao, G., Ren, R., Lisco, S. J., Zucker, I. H., Wang, D., & Wang, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.22.683960 · Cited by 1
Metabolic Regulation of Endothelial Dysfunction and Cardiovascular Risk
Young, J. M. (2012) · Otago University Research Archive (University of Otago)
Inflamación y disfunción endotelial en la insuficiencia cardíaca aguda y crónica
Sánchez-Lázaro, I. J., Bonet, L. A., Vila, V., Sales, V. M., Regañón, E., Martínez‐Dolz, L., & Sanz, A. S. (2012) · Redalyc (Universidad Autónoma del Estado de México)
Patogênese da endomiocardiofibrose: perfil imunológico e análise proteômica de tecido cardíaco
Bossa, A. S. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-17102013-121601
Role of inflammation and extracellular matrix remodelling in dogs with cardiac and systemic diseases
Fonfara, S. (2013) · Työväentutkimus Vuosikirja
Role of Innate Immune Dysregulation in Diabetic Heart Failure
Dokken, B. B., & McDonagh, P. F. (2007) · doi:10.1002/9780470692325.ch19
Utilizing Multimarker Strategies in Patients who Present with Congestive Heart Failure
Mair, J. M. (2007) · doi:10.1002/9780470691984.ch17
The Effect Of Typhoid Fever On Cytokines (Interleukin-6 And 8) And C–Reactive Protein Concentration
ali, A. H., Saleh, E. S., Keetani, A. A., & Joodi, K. K. (2012)
Alterações na produção de TNF-a e IL-10 no músculo esquelético de ratos com insuficiência cardíaca secundária a infarto do miocárdio: possível efeito antiinflamatório do treinamento aeróbio moderado.
Júnior, M. L. B. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2007.tde-18022008-091327
I mediatori dell'infiammazione in corso di insufficienza cardiaca secondaria a endocardiosi mitralica ed insufficienza valvolare nel cane
Mavropoulou, A. (2012) · DSpaceUnipr (University of Parma)
Efecto de la terapia de resincronización cardiaca sobre los niveles de PCN e IL-10 en pacientes con miocardiopatía dilatada
Guzmán, F. J. G., Nolasco, R. R., Montaño, L. F., & Chimal, J. L. A. (2009) · Cardiovascular and Metabolic Science
A clinical and health economical observational study of anti-tumor necrosis factor therapy in the treatment of rheumatoid arthritis in Finland
Virkki, L. (2014) · Työväentutkimus Vuosikirja
What mediated the beneficial roles of methotrexate in chronic heart failure?
Gong, K., Zhang, Z., & Song, G. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.01.020
THE ACUTE EFFECTS OF TWO DIFFERENT TRAINING MODELS ON MARKERS OF INFLAMMATORY ACTIVATION AND SKELETAL MUSCLE INJURY IN PATIENTS WITH CHRONIC HEART FAILURE: 11:00 AM
Taylor, A., Ignaszewski, A., Macintyre, D. L., Mckenzie, D., Hill, J., & Warburton, D. (2008) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/01.hcr.0000336150.09687.c9
Chemokine-receptor Mediated Dendritic Cell and T-cell Recirculation in Heart Failure and Transplantation
Athanassopoulos, P. (2006) · RePub (Erasmus University Rotterdam)
Assessing the Most Effective Depth for PPI Analysis
Blayney, J. K., Zheng, H., Wang, H., & Azuaje, F. J. (2009) · International Joint Conferences on Bioinformatics, Systems Biology and Intelligent Computing · doi:10.1109/ijcbs.2009.82
The Achilles point of cardiac cachexia: To exercise or not to exercise
Kaşıkçıoğlu, E. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.09.031
Anemia and iron in heart failure – A brief comment
Nunes, J. P. L. (2015) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2015.08.001
Acute and recovery responses of serum IL-6 to one bout moderate exercise test in obese men
(2014) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/5.8.267-273
Early inflammatory response during development of right ventricular heart failure in rat
Campian, M. E., Hardziyenka, M., & de Bruin, K. M. (2010)
Interleukin-1 beta response to an acute incremental cycling in obese men
Eizadi, M., Khorshidi, D., MohammadAli, S., & Hussein, D. (2011)
Anti-inflammatory property of short-term regular exercise training in the absence of weight loss
(2013) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/3.3.176-181
TNF-α and IL-10 Modulate CK and CK-MB Activities in Naturally Infected Dogs by Leishmania infantum
de Freitas, J. C. C., Lima, A. L., Rodriguês, C. T. D. A., de Almeida, G. K. G., Santos, G. J. L., Roatt, B. M., Reis, A. B., & Nunes‐Pinheiro, D. C. S. (2014) · Redalyc (Universidad Autónoma del Estado de México)
Cardioprotective Role of the Cholinergic System
Dakroub, M. (2015) · Scholarship@Western (Western University)
Relation of Left Ventricular Ejection Fraction and Functional Capacity With Metabolism and Inflammation in Chronic Heart Failure With Reduced Ejection Fraction (from the MIMICA Study)
Cheitlin, M. D. (2011) · Yearbook of Cardiology · doi:10.1016/j.ycar.2010.10.002
Marcadores genéticos e inflamatórios na insuficiência cardíaca: o impacto do exercício físico
Fernandes-Silva, M. M. (2016) · doi:10.11606/t.5.2016.tde-08042016-145939
SERUM MYELOPEROXIDASE LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE
Garakyaraghi, M., Givi, M., Sadeghi, M., Ali, P., & Nehzat, A. (2015)
Clinical Research Longitudinal Assessment of Inflammation in Recipients of Continuous-Flow Left Ventricular Assist Devices
Grosman‐Rimon, L., Jacobs, I. A., Tumiati, L. C., McDonald, M. A., Bar-Ziv, S. P., Fuks, A., Kawajiri, H., Shogilev, D. J., Cherney, D. Z. I., & Rao, V. (2015)
Plant Statins and Heart Failure
Celık, T., & Çelik, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-396485-4.00002-5
Thrombospondin: An emerging keystone in skeletal muscle structure and function
Audet, G. N. (2013) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.3647
Biomarkers and Cancer Therapy-Related Cardiac Dysfunction
Sharma, P., Rehman, M., Butler, J., & Bloom, M. W. (2016) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-016-0517-2
Prognostic value of VE/VCO2 and interleukin-6 in chronic heart failure subjects
Pereira, D. A. G., Neves, V. R., Montemezzo, D., Parreira, V. F., Alencar, M. C. N., Mendes, L. P. D. S., Pereira, L., & Britto, R. R. (2017) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2017.01.003
Znaczenie stosunku liczby neutrofili do limfocytów jako czynnika predykcyjnego dysfunkcji rozkurczowej lewej komory serca u chorych z przewlekłą chorobą nerek
Gromadziński, L., Januszko‐Giergielewicz, B., Jalali, R., Arłukowicz, T., & Pruszczyk, P. (2018) · Folia Cardiologica · doi:10.5603/fc.2018.0001
Distinguishing heart failure with preserved ejection fraction from heart failure with reduced ejection fraction using proteomics techniques
Mbasu, R. J. (2016) · Figshare
Inflammation and Heart Failure
Kim, K., Kim, D. J., & Eisen, H. J. (2017) · Springer eBooks · doi:10.1007/978-1-4471-4219-5_35
Der Stellenwert von Biomarkern zur Prognoseabschätzung bei diastolischer Dysfunktion und HFpEF
Gonschior, S. (2017) · doi:10.53846/goediss-6141
OBSOLETE: Frailty in Heart Failure Patients
Hritz, C. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11047-5
OBSOLETE: Stage B Heart Failure
Aljabban, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64160-0
Tumor necrosis factor induced oxidative stress in the central nervous system contributes to sympathoexcitation in heart failure
Guggilam, A. (2009) · Louisiana State University · doi:10.31390/gradschool_dissertations.1329
PHARMACOLOGICAL EFFECTS OF GEMFIBROZIL ON SOME CARDIOVASCULAR PREPARATIONS OF EXPERIMENTAL ANIMALS
Ouda, E. A. E.-A. (2016) · Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences · doi:10.21608/ajps.2016.6914
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox
Emdin, M., Aimo, A., Mirizzi, G., & Piacenti, M. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.04.113
Falla cardíaca en pacientes pediátricos. Fisiopatología y manejo. Parte I
Cassalett-Bustillo, G. (2018) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2018.02.003
Heart failure and kidney Crucial & Common pathophysiological pathways
Peralta, M. R. (2017) · Journal of Cardiology and Cardiovascular Sciences · doi:10.29245/2578-3025/2018/1.1105
Desnutrição e caqueixa em pacientes internados com insuficiência cardíaca descompensada: ocorrência e valor prognóstico
Tavares, L. C. A. (2019) · doi:10.11606/d.5.2019.tde-15012019-090034
Hemodynamic Determinants of Right Heart Failure are Associated with Impaired T Cell Activation in Advanced Heart Failure
Alvarez, P. A., Kitai, T., Sperry, B. W., Pérez, A. L., & Tang, W. H. W. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.06.005
Novel approaches to management of congestive heart failure in dogs and cats
Yata, M. (2018) · The Sydney eScholarship Repository (The University of Sydney)
Role of Natural Compounds in Inflammation and Inflammatory-Related Diseases
Μaione, F. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-553-9
Biomarkers of Inflammation
Bozkurt, B. (2006) · Humana Press eBooks · doi:10.1007/978-1-59745-051-5_19
Myocardial Macrophage Phenotypic Variation and Cytokine-Mediated Induction of HIV-Associated Cardiac Disease: A Dissertation
Yearley, J. H. (2008) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/srsk-fg92
Efeitos da eletroestimulação neuromuscular periférica na insuficiência cardíaca crônica
Sacilotto, M. (2017) · doi:10.47749/t/unicamp.2017.987170
Efeitos da estimulação elétrica de baixa frequência no remodelamento e desempenho muscular, resposta oxidativa e inflamatória em pacientes com insuficiência cardíaca
da Silva, M. L. (2017) · doi:10.26512/2017.03.t.23435
Evaluierung immunmodulatorischer microRNAs im Rahmen von Immunoseneszenz und chronischer Herzinsuffizienz
Bach, F. (2021) · doi:10.21248/gups.61470
Óleo essencial de Citrus aurantifolia
Moraes, F. D. S. R. (2014) · doi:10.47749/t/unicamp.2014.927651
<![CDATA[Physiologic left ventricular reconstruction: the concept of maximum ventricular reduction and minimum inflammatory reaction]]>
Gomes, W. J., Jaramillo, J. I., Asanuma, F., & Alves, F. A. (2004) · Brazilian Journal of Cardiovascular Surgery · doi:10.1590/s1678-97412004000400005
Anemia and iron in heart failure – A brief comment
Nunes, J. P. L. (2015) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2015.10.017
Cardiac disease
Gallagher, R. E., & Kimel, G. (2012) · doi:10.1093/acprof:oso/9780199694143.003.0095
Frailty in Heart Failure Patients
Pedraza, S., Barrett, T. A., & Hritz, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.11047-6
Stage B Heart Failure
Aljabban, J., Baliga, R., & Aljabban, I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.64160-1
Molecular dynamics of iron transport in iron disorders
Chang, J. (2019) · doi:10.17760/d20321689
Anaemia and iron deficiency
Kalra, P. R., & Pope, M. (2022) · doi:10.1093/med/9780198766223.003.0031

Authors: Anker, S. D., & von Haehling, S.
Affiliations: Imperial College London (GB)
Department of Clinical Cardiology, Imperial College School of Medicine, National Heart & Lung Institute, London, UK
Corresponding author: Anker, Stefan D
ORCID: Anker, Stefan D
Venue: Heart
Publisher: BMJ
Published: 2004-03-12
Volume: 90
Issue: 4
Pages: 464-470
ISSN: 1355-6037 (ISSN-L)
1468-201X
DOI: 10.1136/hrt.2002.007005
PMC: PMC1768165
OpenAlex: W2104179458
Cited by: 627
References: 33
Citations by year: 2026: 21 · 2025: 14 · 2024: 23 · 2023: 17 · 2022: 27 · 2021: 26 · 2020: 23 · 2019: 36 · 2018: 43 · 2017: 43 · 2016: 34 · 2015: 18 · 2014: 35 · 2013: 30 · 2012: 32
FWCI: 16.81
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Heart (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Deutsche Herzstiftung
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
Keywords: chronic heart failure, inflammation, inflammatory mediators, inflammatory cytokines, anti-inflammatory cytokines, neuroendocrine activation, neurohormones, endotoxin, adhesion molecules, nitric oxide, reactive oxygen species, leukocytes, immune system, heart failure pathophysiology, anti-inflammatory therapy
MeSH terms: Etanercept, Infliximab, Anti-Inflammatory Agents, Non-Steroidal, Antibodies, Monoclonal, C-Reactive Protein, Heart Failure, Humans, Immunoglobulin G, Leukocytes, Myocarditis, Nitric Oxide, Tumor Necrosis Factor-alpha, Cell Adhesion Molecules, Lymphocyte Subsets, Cytokines, Receptors, Tumor Necrosis Factor, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inflammatory mediators in chronic heart failure: an overview

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks